Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2022-05-24 (3 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CONDE-SUR-L'ESCAUT (59163), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE LEGRAND : revenue, balance sheet and financial ratios
SELARL PHARMACIE LEGRAND is a French company
founded 3 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CONDE-SUR-L'ESCAUT (59163),
this company of category PME
shows in 2024 a net income positive of 162 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE LEGRAND (SIREN 913903332)
Indicator
2024
2023
Revenue
N/C
N/C
Net income
161 844 €
-89 562 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE LEGRAND generates positive net income of 162 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
161 844 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1634%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 5%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1634.227%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
4.74%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
2024
Debt ratio
29290.859
1634.227
Financial autonomy
0.291
4.74
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
1634.232024
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of SELARL PHARMACIE LEGRAND (1634.23) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
4.74%2024
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of SELARL PHARMACIE LEGRAND (4.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 140.18. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
2024
Liquidity ratio
146.004
140.182
Interest coverage
None
None
Sector positioning
Liquidity ratio
140.182024
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average
In 2024, the liquidity ratio of SELARL PHARMACIE LEGRAND (140.18) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELARL PHARMACIE LEGRAND in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE LEGRAND is estimated at
2 259 461 €
(range 1 573 453€ - 3 380 284€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1573k€2259k€3380k€
2 259 461 €Range: 1 573 453€ - 3 380 284€
NAF 5 année 2024
Valuation method used
Net Income Multiple
161 844 €
×
14.0x
=2 259 462 €
Range: 1 573 454€ - 3 380 284€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE LEGRAND with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE LEGRAND
What is the revenue of SELARL PHARMACIE LEGRAND ?
The revenue of SELARL PHARMACIE LEGRAND is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE LEGRAND profitable?
Yes, SELARL PHARMACIE LEGRAND generated a net profit of 162 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE LEGRAND ?
The headquarters of SELARL PHARMACIE LEGRAND is located in CONDE-SUR-L'ESCAUT (59163), in the department Nord.
Where to find the tax return of SELARL PHARMACIE LEGRAND ?
The tax return of SELARL PHARMACIE LEGRAND is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE LEGRAND operate?
SELARL PHARMACIE LEGRAND operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart